250
Participants
Start Date
November 30, 2012
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
FEC3-D3
"Fluorouracil 500 mg/m2, every 3 weeks Epirubicin 100 mg/m2, every 3 weeks Cyclophosphamide 500, every 3 weeks~Docetaxel 75 mg/m2, every 3 weeks"
Asan Medical Center, Seoul
Lead Sponsor
Asan Medical Center
OTHER